CGEM Financing Cash Flow

Cullinan Therapeutics Inc · Financing Cash Flow

CGEM logo

CGEM Financing Cash Flow

Latest reported$2.20M
CGEM TTM Cash from Financing ($85.72M → $2.20M)
High-resolution chart · PNG

CGEM financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Cullinan Therapeutics Inc Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
2,195,000
1,468,000
1,088,000
1,955,000
3,280,000
265,103,000
266,188,000
264,854,000
263,641,000
40,047,000
40,751,000
7,591,000
8,904,000
-27,685,000
-25,933,000
9,681,000
8,835,000
7,745,000
268,784,000
390,979,000
391,606,000
390,683,000
140,140,000
99,157,000
97,909,000
98,830,500
85,715,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.